Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 1981;319:369–377. doi: 10.1113/jphysiol.1981.sp013914

β-receptor numbers and thermodynamics in denervation supersensitivity

R Bannister 1, A W Boylston 1, I B Davies 1,*, C J Mathias 1, P S Sever 1, D Sudera 1
PMCID: PMC1243844  PMID: 6275073

Abstract

1. Denervation supersensitivity to adrenergic agonists occurs after degeneration of the sympathetic nervous system in the disease called multiple system atrophy (MSA) or the Shy Drager Syndrome.

2. Supersensitivity to the chronotropic effect of i.v. isoprenaline on the heart was demonstrated in eight subjects with sympathetic nervous system degeneration and MSA.

3. There was an increased number of β-receptors present in MSA as measured by [H3]dihydroalprenolol ([H3]DHA) binding to β-receptors on lymphocytes isolated from venous blood taken from the MSA subjects compared with [H3]DHA binding to lymphocytes from seven normal subjects. There was no difference in the affinity of lymphocyte β-receptors for [H3]DHA in MSA.

4. [H3]DHA binding to lymphocytes from MSA subjects was decreased at lower temperatures but was unaffected by lower temperatures in lymphocytes from normal subjects.

5. Equilibrium constants for [H3]DHA binding to normal and MSA lymphocytes were similar, indicating that the affinity of the β-receptors was similar in both groups. The equilibrium constants were little affected by cooling from 37 to 4 °C suggesting that the heat of reaction (enthalpy) for [H3]DHA binding was low. The Gibbs free energy change on binding was negative and similar in quantity for both normal and MSA lymphocytes. There was a similar, large, increase in entropy on binding of [H3]DHA to both normal and MSA lymphocytes, showing that the binding reaction was entropy driven.

6. If lymphocyte β-receptors reflect the status of cardiac β-receptors, increased numbers of cardiac β-receptors may contribute to the denervation supersensitivity to isoprenaline in MSA with sympathetic degeneration.

Full text

PDF
369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannister R., Davies B., Holly E., Rosenthal T., Sever P. Defective cardiovascular reflexes and supersensitivity to sympathomimetic drugs in autonomic failure. Brain. 1979 Mar;102(1):163–176. doi: 10.1093/brain/102.1.163. [DOI] [PubMed] [Google Scholar]
  2. Bannister R., Sever P., Gross M. Cardiovascular reflexes and biochemical responses in progressive autonomic failure. Brain. 1977 Jun;100(2):327–344. doi: 10.1093/brain/100.2.327. [DOI] [PubMed] [Google Scholar]
  3. Brûlet P., McConnell H. M. Structural and dynamical aspects of membrane immunochemistry using model membranes. Biochemistry. 1977 Mar 22;16(6):1209–1217. doi: 10.1021/bi00625a028. [DOI] [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Catt K. J., Harwood J. P., Aguilera G., Dufau M. L. Hormonal regulation of peptide receptors and target cell responses. Nature. 1979 Jul 12;280(5718):109–116. doi: 10.1038/280109a0. [DOI] [PubMed] [Google Scholar]
  6. Franklin T. J. Binding energy and the activation of hormone receptors. Biochem Pharmacol. 1980 Mar 15;29(6):853–856. doi: 10.1016/0006-2952(80)90214-2. [DOI] [PubMed] [Google Scholar]
  7. Glaubiger G., Lefkowitz R. J. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun. 1977 Sep 23;78(2):720–725. doi: 10.1016/0006-291x(77)90238-8. [DOI] [PubMed] [Google Scholar]
  8. Glaubiger G., Tsai B. S., Lefkowitz R. J., Weiss B., Johnson E. M., Jr Chronic guanethidine treatment increases cardiac beta-adrenergic receptors. Nature. 1978 May 18;273(5659):240–242. doi: 10.1038/273240a0. [DOI] [PubMed] [Google Scholar]
  9. Henry D. P., Starman B. J., Johnson D. G., Williams R. H. A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Life Sci. 1975 Feb 1;16(3):375–384. doi: 10.1016/0024-3205(75)90258-1. [DOI] [PubMed] [Google Scholar]
  10. Kunos G., Szentivanyi M. Evidence favouring the existence of a single adrenergic receptor. Nature. 1968 Mar 16;217(5133):1077–1078. doi: 10.1038/2171077a0. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Mickelson K. E., Westphal U. Steroid--protein interactions. Influence of steroid structure and temperature on the binding of steroids to guinea pig corticosteroid-binding globulin. Biochemistry. 1980 Feb 5;19(3):585–590. doi: 10.1021/bi00544a030. [DOI] [PubMed] [Google Scholar]
  13. Schocken D. D., Roth G. S. Reduced beta-adrenergic receptor concentrations in ageing man. Nature. 1977 Jun 30;267(5614):856–858. doi: 10.1038/267856a0. [DOI] [PubMed] [Google Scholar]
  14. Scrutton M. C., Grant J. A. Dihydroergocryptine is a non-selective antagonist for human platelet alpha-adrenoreceptors. Nature. 1979 Aug 23;280(5724):700–700. doi: 10.1038/280700a0. [DOI] [PubMed] [Google Scholar]
  15. Shinitzky M., Henkart P. Fluidity of cell membranes--current concepts and trends. Int Rev Cytol. 1979;60:121–147. [PubMed] [Google Scholar]
  16. Sporn J. R., Harden T. K., Wolfe B. B., Molinoff P. B. beta-Adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex. Science. 1976 Nov 5;194(4265):624–626. doi: 10.1126/science.10626. [DOI] [PubMed] [Google Scholar]
  17. Strittmatter W. J., Hirata F., Axelrod J. Phospholipid methylation unmasks cryptic beta-adrenergic receptors in rat reticulocytes. Science. 1979 Jun 15;204(4398):1205–1207. doi: 10.1126/science.221977. [DOI] [PubMed] [Google Scholar]
  18. Vestal R. E., Wood A. J., Shand D. G. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979 Aug;26(2):181–186. doi: 10.1002/cpt1979262181. [DOI] [PubMed] [Google Scholar]
  19. Weiland G. A., Minneman K. P., Molinoff P. B. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor. Nature. 1979 Sep 13;281(5727):114–117. doi: 10.1038/281114a0. [DOI] [PubMed] [Google Scholar]
  20. Williams L. T., Snyderman R., Lefkowitz R. J. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest. 1976 Jan;57(1):149–155. doi: 10.1172/JCI108254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wolff M. E., Baxter J. D., Kollman P. A., Lee D. L., Kuntz I. D., Bloom E., Matulich D. T., Morris J. Nature of steroid-glucocorticoid receptor interactions: thermodynamic analysis of the binding reaction. Biochemistry. 1978 Aug 8;17(16):3201–3208. doi: 10.1021/bi00609a005. [DOI] [PubMed] [Google Scholar]
  22. Yasuda T., Dancey G. F., Kinsky S. C. Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1234–1236. doi: 10.1073/pnas.74.3.1234. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES